In vitro methods in drug transporter interaction assessment.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Drug Discovery Today : Technologies

• Publication date

  2014-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ddtec.2014.03.011PMID 25027368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multidrug resistance ABC transporter structure predictions by homology modeling approaches.

  2011cited by this paper
• Proteasomal Inhibition Promotes ATP-Binding Cassette Transporter A1 (ABCA1) and ABCG1 Expression and Cholesterol Efflux From Macrophages In Vitro and In Vivo

  2011cited by this paper
• Transporter‐Mediated Drug Uptake and Efflux: Important Determinants of Adverse Drug Reactions

  2011cited by this paper
• Transporter‐Mediated Drug–Drug Interactions

  2011cited by this paper
• Double‐transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations

  2011cited by this paper
• In vitro characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short cationic antimicrobial peptides.

  2011cited by this paper
• Transporter-mediated drug-drug interactions.

  2011cited by this paper
• Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.

  2011cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state

  2010cited by this paper
• Effect of Membrane Cholesterol on BSEP/Bsep Activity: Species Specificity Studies for Substrates and Inhibitors

  2009cited by this paper
• Potentiation of MRP2/Mrp2‐Mediated Estradiol‐17β‐Glucuronide Transport by Drugs – A Concise Review

  2009cited by this paper
• A novel screening strategy to identify ABCB1 substrates and inhibitors

  2008cited by this paper
• Utilization of membrane vesicle preparations to study drug–ABC transporter interactions

  2008cited by this paper
• Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions

  2008cited by this paper
• Several major antiepileptic drugs are substrates for human P-glycoprotein.

  2008cited by this paper
• Interaction of Positional Isomers of Quercetin Glucuronides with the Transporter ABCC2 (cMOAT, MRP2)

  2007cited by this paper
• Cholesterol Potentiates ABCG2 Activity in a Heterologous Expression System: Improved in Vitro Model to Study Function of Human ABCG2

  2007cited by this paper
• ABCG2 (Breast Cancer Resistance Protein/Mitoxantrone Resistance-Associated Protein) ATPase Assay: A Useful Tool to Detect Drug-Transporter Interactions

  2007cited by this paper
• The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics.

  2006cited by this paper
• Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

  2006cited by this paper
• Evaluation of human P-glycoprotein (MDR1/ABCB1) ATPase activity assay method by comparing with in vitro transport measurements: Michaelis-Menten kinetic analysis to estimate the affinity of P-glycoprotein to drugs.

  2006cited by this paper
• Human Hepatobiliary Transport of Organic Anions Analyzed by Quadruple-Transfected Cells

  2005cited by this paper
• Identification of the Hepatic Efflux Transporters of Organic Anions Using Double-Transfected Madin-Darby Canine Kidney II Cells Expressing Human Organic Anion-Transporting Polypeptide 1B1 (OATP1B1)/Multidrug Resistance-Associated Protein 2, OATP1B1/Multidrug Resistance 1, and OATP1B1/Breast Cancer R

  2005cited by this paper
• Caco-2 cell permeability assays to measure drug absorption

  2005cited by this paper
• The Complexities of Hepatic Drug Transport: Current Knowledge and Emerging Concepts

  2004cited by this paper
• Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein*

  2003cited by this paper
• Experimental estimation of the role of P-Glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model.

  2003cited by this paper
• Evidence for Two Interacting Ligand Binding Sites in Human Multidrug Resistance Protein 2 (ATP Binding Cassette C2)*

  2003cited by this paper
• Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.

  2000cited by this paper
• Transporter-mediated permeation of drugs across the blood-brain barrier.

  2000cited by this paper
• Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine.

  2000cited by this paper
• Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.

  1999cited by this paper
• Diagnostics of multidrug resistance in cancer.

  1998cited by this paper
• Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans

  1997cited by this paper
• Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase.

  1992cited by this paper
• Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells.

  1992cited by this paper
• Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

  1990cited by this paper
• ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.

  1988cited by this paper
• Reduced cyclosporin accumulation in multidrug-resistant cells.

  1988cited by this paper
• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

  1976cited by this paper
• Inside-Out Red Cell Membrane Vesicles: Preparation and Puirification

  1970cited by this paper
• SARCOPLASMIC RETICULUM. I. THE UPTAKE OF CA++ BY SARCOPLASMIC RETICULUM FRAGMENTS.

  1964cited by this paper

• A Structural Bioinformatics-Guided Study of Adenosine Triphosphate-Binding Cassette (ABC) Transporters and Their Substrates

  2025cites this paper
• Interactions of human drug transporters with chemical additives present in plastics: Potential consequences for toxicokinetics and health.

  2023cites this paper
• Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021

  2022cites this paper
• A GC-MS/Single-Cell Method to Evaluate Membrane Transporter Substrate Specificity and Signaling

  2021cites this paper
• Role of P-glycoprotein in the brain disposition of seletalisib: Evaluation of the potential for drug-drug interactions.

  2020cites this paper
• Papel del transportador ABCG2/BCRP y sus polimorfismos en la secreción activa de compuestos a leche y su modulación a través de compuestos naturales en rumiantes

  2019influential citation
• Discovery and Characterization of Novel Substrate Selective Inhibitors of Human MRP1 (ABCC1)

  2019cites this paper
• Prediction of Human Pharmacokinetics and Pharmacodynamics

  2018cites this paper
• Effect of bovine ABCG2 polymorphism Y581S SNP on secretion into milk of enterolactone, riboflavin and uric acid.

  2016cites this paper
• Quantitative aspects of drug permeation across in vitro and in vivo barriers.

  2016cites this paper
• INTERACTION OF BAICALIN WITH TRANSPORTERS

  2016cites this paper
• Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro.

  2015cites this paper
• Nature and uses of fluorescent dyes for drug transporter studies

  2015cites this paper
• Unexpected retention behavior of baicalin: Hydrophilic interaction like properties of a reversed-phase column.

  2015cites this paper
• SLC transporters as therapeutic targets: emerging opportunities

  2015cites this paper